156 related articles for article (PubMed ID: 15557427)
21. The study of c-Src kinase and pStat3 protein expression in retinoblastoma.
Mohan A; Mallikarjuna K; Venkatesan N; Abhyankar D; Parikh PM; Krishnakumar S
Exp Eye Res; 2006 Oct; 83(4):736-40. PubMed ID: 16716300
[TBL] [Abstract][Full Text] [Related]
22. Relationship between histopathological features of chemotherapy treated retinoblastoma and P-glycoprotein expression.
Souza Filho JP; Martins MC; Caissie AL; Torres VL; Fernandes LH; Erwenne CM; Burnier MN
Clin Exp Ophthalmol; 2005 Jun; 33(3):279-84. PubMed ID: 15932532
[TBL] [Abstract][Full Text] [Related]
23. Immunohistochemical expression of CD117 and vascular endothelial growth factor in retinoblastoma: possible targets of new therapies.
Youssef NS; Said AM
Int J Clin Exp Pathol; 2014; 7(9):5725-37. PubMed ID: 25337214
[TBL] [Abstract][Full Text] [Related]
24. Expression of p63 and p73 in retinoblastoma: a clinicopathological correlation study.
Adithi M; Nalini V; Kandalam M; Krishnakumar S
Exp Eye Res; 2008 Oct; 87(4):312-8. PubMed ID: 18619959
[TBL] [Abstract][Full Text] [Related]
25. Major histocompatibility antigens and antigen-processing molecules in retinoblastoma.
Krishnakumar S; Sundaram A; Abhyankar D; Krishnamurthy V; Shanmugam MP; Gopal L; Sharma T; Biswas J
Cancer; 2004 Mar; 100(5):1059-69. PubMed ID: 14983503
[TBL] [Abstract][Full Text] [Related]
26. [Clinicopathologic features of retinoblastoma and expression of VEGF and Ki-67 after comprehensive treatment].
Xue K; Qian J; Bi YW; Yao YQ; Yuan YF; DA CD
Zhonghua Yan Ke Za Zhi; 2011 Feb; 47(2):134-41. PubMed ID: 21426843
[TBL] [Abstract][Full Text] [Related]
27. Intracranial malignancy in patients with bilateral retinoblastoma.
Donoso LA; Shields JA; Felberg NT; Martyn LJ; Truex RC; D'Cruz CA
Retina; 1981; 1(1):67-74. PubMed ID: 15633409
[TBL] [Abstract][Full Text] [Related]
28. Microarray analysis and biochemical correlations of oxidative stress responsive genes in retinoblastoma.
Vandhana S; Lakshmi TS; Indra D; Deepa PR; Krishnakumar S
Curr Eye Res; 2012 Sep; 37(9):830-41. PubMed ID: 22668346
[TBL] [Abstract][Full Text] [Related]
29. Clinicopathologic study of retinoblastoma including MIB-1, p53, and CD99 immunohistochemistry.
Schwimer CJ; Prayson RA
Ann Diagn Pathol; 2001 Jun; 5(3):148-54. PubMed ID: 11436168
[TBL] [Abstract][Full Text] [Related]
30. Clinicopathologic significance of EpCAM expression in squamous cell carcinoma of the tongue and its possibility as a potential target for tongue cancer gene therapy.
Yanamoto S; Kawasaki G; Yoshitomi I; Iwamoto T; Hirata K; Mizuno A
Oral Oncol; 2007 Oct; 43(9):869-77. PubMed ID: 17207659
[TBL] [Abstract][Full Text] [Related]
31. Clinical relevance of B7H3 expression in retinoblastoma.
Ganesan B; Parameswaran S; Sharma A; Krishnakumar S
Sci Rep; 2020 Jun; 10(1):10185. PubMed ID: 32576886
[TBL] [Abstract][Full Text] [Related]
32. A histopathologic analysis of 50 eyes primarily enucleated for retinoblastoma in a tertiary cancer center in Jordan.
Yousef YA; Hajja Y; Nawaiseh I; Mehyar M; Sultan I; Deebajah R; Rawashdeh K; Khurma S; Jaradat I; Al-Hussaini M
Turk Patoloji Derg; 2014; 30(3):171-7. PubMed ID: 24913302
[TBL] [Abstract][Full Text] [Related]
33. Clinicopathological parameters and expression of P-glycoprotein and MRP-1 in retinoblastoma.
Kamburoğlu G; Kiratli H; Söylemezoğlu F; Bilgiç S
Ophthalmic Res; 2007; 39(4):191-7. PubMed ID: 17596751
[TBL] [Abstract][Full Text] [Related]
34. High expression of TAZ indicates a poor prognosis in retinoblastoma.
Zhang Y; Xue C; Cui H; Huang Z
Diagn Pathol; 2015 Oct; 10():187. PubMed ID: 26464030
[TBL] [Abstract][Full Text] [Related]
35. [Histopathologic findings in retinoblastoma].
de Souza Filho JP; Martins MC; Torres VL; Dias AB; Lowen MS; Pires LA; Erwenne CM
Arq Bras Oftalmol; 2005; 68(3):327-31. PubMed ID: 16059563
[TBL] [Abstract][Full Text] [Related]
36. [The extension of retinoblastoma into neighboring structures].
Bosun I; Simionescu C
Oftalmologia; 1998; 44(3):47-52. PubMed ID: 10418613
[TBL] [Abstract][Full Text] [Related]
37. Expression of pro-apoptotic Bax and anti-apoptotic Bcl-2 proteins in human retinoblastoma.
Singh L; Pushker N; Saini N; Sen S; Sharma A; Bakhshi S; Chawla B; Kashyap S
Clin Exp Ophthalmol; 2015 Apr; 43(3):259-67. PubMed ID: 25132102
[TBL] [Abstract][Full Text] [Related]
38. [Follow-up of retinoblastoma during homeopathic therapy].
Käsmann-Kellner B; Graf N; Elflein E; Ruprecht KW; Sitzmann CF
Klin Monbl Augenheilkd; 1999 Apr; 214(4):aA12-6. PubMed ID: 10407798
[No Abstract] [Full Text] [Related]
39. Clinical pathologic study of a cohort of patients with retinoblastoma from a developing country.
Orellana ME; Fernandes BF; Arean C; Pifano I; Al-Kandari A; Burnier MN
J Pediatr Ophthalmol Strabismus; 2009; 46(5):294-9. PubMed ID: 19791727
[TBL] [Abstract][Full Text] [Related]
40. Stem cell markers: ABCG2 and MCM2 expression in retinoblastoma.
Mohan A; Kandalam M; Ramkumar HL; Gopal L; Krishnakumar S
Br J Ophthalmol; 2006 Jul; 90(7):889-93. PubMed ID: 16556617
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]